Breaking News Instant updates and real-time market news.

C

Citi

$72.70

0.07 (0.10%)

, USB

U.S. Bancorp

$51.08

-0.1 (-0.20%)

14:21
05/15/18
05/15
14:21
05/15/18
14:21

House to vote next week on bill easing bank regulations, CNBC reports

The House expects to vote next Tuesday on a Senate-passed bill that would roll back some regulations on banks, CNBC reports, citing four sources. Publicly traded companies in the bank space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link

C

Citi

$72.70

0.07 (0.10%)

USB

U.S. Bancorp

$51.08

-0.1 (-0.20%)

JPM

JPMorgan

$113.00

-0.91 (-0.80%)

BAC

Bank of America

$31.22

0.1 (0.32%)

GS

Goldman Sachs

$242.02

-1.86 (-0.76%)

WFC

Wells Fargo

$54.77

0.29 (0.53%)

MS

Morgan Stanley

$54.99

-0.23 (-0.42%)

  • 15

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 17

    May

  • 23

    May

  • 30

    May

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

C Citi
$72.70

0.07 (0.10%)

04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/05/18
04/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Overweight from Equal Weight at Barclays with analyst Geoffrey Meacham saying he believes the company will continue to take share in first-line lung cancer, driven by positive KN-189 and KN-042 data. 2. Acuity Brands (AYI) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he believes the stock is finally trading at a "reasonable valuation based on reasonable expectations." 3. AMD (AMD) upgraded to Buy from Hold at Stifel with analyst Kevin Cassidy citing valuation and the company's margin expansion potential. 4. Tiffany (TIF) upgraded to Buy from Hold at Loop Capital with analyst Laura Champine saying her initial meeting with the company's new CEO Alessandro Bogliogo added to her confidence. 5. Citi (C) and Wells Fargo (WFC) were upgraded to Buy from Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/18
HSBC
04/11/18
UPGRADE
Target $85
HSBC
Buy
Citi upgraded to Buy from Hold at HSBC
HSBC analyst Alevizos Alevizakos upgraded Citi to Buy and raised his price target for the shares to $85 from $82. The analyst sees improved profitability in the near-term, driven by U.S. dollar depreciation and tax reform, re-rating the shares higher. He believes the market is not fully appreciating Citi's leading credit card franchise and its growth prospects in Mexico.
04/11/18
04/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Citi (C) upgraded to Buy from Hold at HSBC with analyst Alevizos Alevizakos saying he sees improved profitability in the near-term, driven by U.S. dollar depreciation and tax reform, re-rating the shares higher. 2. BHP Billiton (BHP) upgraded to Buy from Hold at Deutsche Bank with analyst Liam Fitzpatrick saying the shares offer compelling value at current levels. 3. Mattel (MAT) upgraded to Hold from Underperform at Jefferies with analyst Stephanie Wissink saying the company's near-term risks are largely known and priced into the shares. 4. AeroVironment (AVAV) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he sees the company benefiting from tailwinds including an improving defense budget environment, a heightened global threat environment, and "as strong a pipeline of opportunities" as he has seen in ten years. 5. Helmerich & Payne (HP) upgraded to Market Perform from Underperform at Wells Fargo with analyst Judson Bailey citing strength in the land rig market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
USB U.S. Bancorp
$51.08

-0.1 (-0.20%)

04/04/18
DBAB
04/04/18
UPGRADE
Target $50
DBAB
Buy
Citizens Financial upgraded to Buy with $50 target at Deutsche Bank
Deutsche Bank analyst Matthew O'Connor last night upgraded Citizens Financial Group (CFG) to Buy with an unchanged price target of $50. The analyst upgrades the stock following the recent pullback ahead of the Q1 earnings season. U.S. Bancorp (USB) remains his top pick among U.S. Banks.
05/11/18
SBSH
05/11/18
UPGRADE
SBSH
Buy
U.S. Bancorp upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded U.S. Bancorp to Buy with a $58 price target.
05/11/18
SBSH
05/11/18
UPGRADE
Target $58
SBSH
Buy
Citi upgrades U.S. Bancorp, says opportune time to build positions
Citi analyst Keith Horowitz upgraded U.S. Bancorp to Buy from Neutral with an unchanged price target of $58. Now is an opportune time to build positions in the stock after three years of significant underperformance, Horowitz tells investors in a research note. He believes the drivers of the underperformance have largely played out and that U.S. Bancorp's efficiency ratio will improve from here. Further, the bank's "strong" credit quality profile can be a differentiator as the cycle gets into the latter innings, Horowitz contends. He says U.S. Bancorp is one of the best ways for investors looking to add exposure to the banks.
05/11/18
05/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying after a meeting with CEO Lowell McAdam, he has a better understanding that Verizon's "organic approach to wireless has the company on an increasingly stable footing." 2. Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital with analyst Andrew Wong saying that it is "hard to ignore the improving undercurrents in both phosphate and potash markets." 3. Ultragenyx (RARE) upgraded to Overweight from Equal Weight at Barclays with analyst Gena Wang saying she thinks a higher price target for Crysvita could drive upside to revenue growth expectations. 4. U.S. Bancorp (USB) upgraded to Buy from Neutral at Citi with analyst Keith Horowitz saying now is an opportune time to build positions in the stock after three years of significant underperformance. 5. AMC Networks (AMCX) upgraded to Buy from Hold at Gabelli with the firm saying it remains an excelling company with opportunities to leverage its recent programming momentum into increased advertising and affiliate fees. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JPM JPMorgan
$113.00

-0.91 (-0.80%)

04/02/18
KEYB
04/02/18
NO CHANGE
KEYB
Efforts to strengthen in-store healthcare offering positive for Walmart, says KeyBanc
KeyBanc analyst Edward Yruma notes that the push to provide consumer-driven and lower-cost healthcare continues its push into retail as The Wall Street Journal reports that Walmart (WMT) is in discussions to acquire or develop a closer partnership Humana (HUM). This is on the heels of Amazon's (AMZN) recent JV with Berkshire Hathaway (BRK.A; BRK.B) and JPMorgan (JPM) to provide healthcare for employees, he adds. The analyst views any efforts to strengthen the in-store healthcare offering as a positive for Walmart's stock.
04/11/18
HSBC
04/11/18
INITIATION
Target $111
HSBC
Hold
JPMorgan initiated with a Hold at HSBC
HSBC analyst Alevizos Alevizakos started JPMorgan with a Hold rating and $111 price target. The analyst sees minimal share upside from current valuation levels.
04/11/18
04/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), Apple (AAPL), and Facebook (FB) were initiated with a Buy at Monness Crespi. 2. Caterpillar (CAT) initiated with a Buy at Buckingham. 3. JPMorgan (JPM) initiated with a Hold at HSBC. 4. eBay (EBAY) assumed with an Overweight at KeyBanc. 5. Ericsson (ERIC) initiated with a Hold at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
BAC Bank of America
$31.22

0.1 (0.32%)

01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
GS Goldman Sachs
$242.02

-1.86 (-0.76%)

04/18/18
OPCO
04/18/18
NO CHANGE
Target $308
OPCO
Outperform
Goldman Sachs price target raised to $308 from $280 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised his price target for Goldman Sachs to $308 from $280 after the company posted a "strong" rebound from last year's dismal quarter and posted a significant upside surprise. The analyst reiterates an Outperform rating on the shares.
04/18/18
BMOC
04/18/18
NO CHANGE
Target $245
BMOC
Market Perform
Goldman Sachs price target raised to $245 from $221 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs (GS) to $245 after the company's Q1 revenue beat, saying it is "back to stealing market share in its core business" as its FICC - fixed income, currencies, and commodities - trading rose 23% vs. a 4% decline for peers. The analyst adds that while Goldman Sachs will continue to experience positive operating leverage, its valuation relative to Morgan Stanley (MS) cannot be justified, favoring the latter based on its greater exposure to higher-multiple asset management businesses. Fotheringham keeps his Market Perform rating on Goldman Sachs.
04/18/18
ARGS
04/18/18
NO CHANGE
ARGS
Hold
Goldman Sachs earnings inherently 'volatile', says Argus
Argus analyst Stephen Biggar keeps his Hold rating on Goldman Sachs after its Q1 earnings beat, saying the company's as "strength in underwriting, equities trading and securities lending offset weaker financial advisory revenue". Biggar further notes that as a "capital markets pure play", Goldman Sachs has move volatile earnings than other large global banks and is more dependent on client activity. The analyst further cites Q1 outperformance as a result of a "ripe environment" for Goldman's business mix, but does not expect market volatility to continue.
04/18/18
FBCO
04/18/18
NO CHANGE
Target $280
FBCO
Neutral
Goldman Sachs price target raised to $280 from $274 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for Goldman Sachs to $280 from $274 following quarterly results. The analyst reiterates a Neutral rating on the shares.
WFC Wells Fargo
$54.77

0.29 (0.53%)

04/16/18
BARD
04/16/18
NO CHANGE
Target $62
BARD
Outperform
Lower expectations limit Wells Fargo downside, says Baird
Baird analyst David George said Wells Fargo reported messy Q1 results, but lowered expectations should limit the downside in the shares. The analyst said core fees were weak, but expenses were in line as was loan growth. George maintained his Outperform rating and $62 price target on Wells Fargo shares.
04/30/18
04/30/18
UPGRADE

Outperform
Wells Fargo double upgraded to Outperform at Macquarie
Macquarie analyst David Konrad upgraded Wells Fargo to Outperform from Underperform with a $61 price target citing attractive valuation, low expectations, and near-term catalysts. Konrad said valuation and consensus estimates have finally come down and said shares are trading at 11.3x his 2019 "stressed earnings" estimate, compared to super regionals trading at 12.3x. The analyst expects low expense guidance at the upcoming investor day and passing CCAR in June to serve as positive catalysts for shares.
04/16/18
NOMU
04/16/18
NO CHANGE
Target $68
NOMU
Buy
Wells Fargo earnings underwhelming, but not a value trap, says Nomura
Nomura Instinet analyst Bill Carcache lowered his price target for Wells Fargo to $68 from $72 saying Friday's earnings results were "underwhelming" as the company reported softer revenue growth. The analyst, however, continues to believe that shares of Wells Fargo are "not a value trap." Shareholders "able to weather the current storm" will be rewarded with 10% earnings growth, mid- to high-teens return on tangible equity, and a multiple rerating when the market regains confidence, Carcache tells investors in a research note. He keeps a Buy rating on the shares.
MS Morgan Stanley
$54.99

-0.23 (-0.42%)

04/19/18
BMOC
04/19/18
NO CHANGE
Target $72
BMOC
Outperform
Morgan Stanley 'richly deserves' higher valuation multiple, says BMO Capital
BMO Capital analyst James Fotheringham kept his Outperform rating and $72 price target on Morgan Stanley after its Q1 earnings beat while also raising his FY18 EPS view to $4.78 from $4.51. The analyst cites his expectations of higher trading revenues and also points to lower EPS volatility relative to that Goldman Sachs (GS), even though Morgan Stanley's multiple of 9.7-times two-year-forward PE is below Goldman's 10-times.
04/09/18
BERN
04/09/18
INITIATION
Target $51
BERN
Underperform
Morgan Stanley initiated with an Underperform at Bernstein
Bernstein initiated Morgan Stanley with an Underperform and $51 price target.
04/06/18
WELS
04/06/18
NO CHANGE
Target $330
WELS
Outperform
Goldman Sachs to benefit from market volatility, says Wells Fargo
Wells Fargo analyst Mike Mayo says rising volatility could push his above consensus estimates for Goldman Sachs (GS) even higher. Goldman could be one of the biggest volatility beneficiaries, Mayo tells investors in a research note. He notes Goldman generates the highest contribution from trading among the large U.S. banks, with Morgan Stanley (MS) being second. The analyst keeps an Outperform rating on Goldman shares with a $330 price target.

TODAY'S FREE FLY STORIES

08:54
11/14/18
11/14
08:54
11/14/18
08:54
Conference/Events
Federal Reserve Bank of Dallas president participates in a discussion »

Federal Reserve Bank of…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

08:53
11/14/18
11/14
08:53
11/14/18
08:53
Recommendations
Qorvo, Lumentum, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

LITE

Lumentum

$38.95

1.445 (3.85%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ON

ON Semiconductor

$17.35

0.54 (3.21%)

, ST

Sensata

$46.37

0.3 (0.65%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Recommendations
ON Semiconductor, Sensata analyst commentary  »

Morgan Stanley says auto…

ON

ON Semiconductor

$17.35

0.54 (3.21%)

ST

Sensata

$46.37

0.3 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 08

    May

CELC

Celcuity

$27.94

-0.13 (-0.46%)

, PBYI

Puma Biotechnology

$22.03

-0.13 (-0.59%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Recommendations
Celcuity, Puma Biotechnology analyst commentary  »

Celcuity price target…

CELC

Celcuity

$27.94

-0.13 (-0.46%)

PBYI

Puma Biotechnology

$22.03

-0.13 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 03

    Dec

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

, GE

General Electric

$8.61

0.625 (7.83%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Syndicate
Baker Hughes 92M share secondary offering by GE prices at $23.00 »

Baker Hughes, a GE…

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

GE

General Electric

$8.61

0.625 (7.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

08:51
11/14/18
11/14
08:51
11/14/18
08:51
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

08:51
11/14/18
11/14
08:51
11/14/18
08:51
Syndicate
Baker Hughes 92M share Secondary priced at $23.00 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

PCG

PG&E

$32.70

-0.25 (-0.76%)

08:50
11/14/18
11/14
08:50
11/14/18
08:50
Recommendations
PG&E analyst commentary  »

PG&E price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.78

0.55 (0.86%)

08:50
11/14/18
11/14
08:50
11/14/18
08:50
Conference/Events
Economic Club of New York to hold a luncheon meeting »

Luncheon Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

08:50
11/14/18
11/14
08:50
11/14/18
08:50
General news
Treasury Action: yields probed higher »

Treasury Action: yields…

08:49
11/14/18
11/14
08:49
11/14/18
08:49
Conference/Events
Federal Reserve Vice Chairman speaks before House Financial Services Committee »

Federal Reserve Vice…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

08:48
11/14/18
11/14
08:48
11/14/18
08:48
Recommendations
Qorvo analyst commentary  »

Qorvo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$6.04

0.19 (3.25%)

08:47
11/14/18
11/14
08:47
11/14/18
08:47
Upgrade
Mersana Therapeutics rating change  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$31.09

-0.495 (-1.57%)

08:46
11/14/18
11/14
08:46
11/14/18
08:46
Conference/Events
The FDA holds a joint committee meeting »

The Anesthetic &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 16

    Nov

PGR

Progressive

$71.63

-0.28 (-0.39%)

08:45
11/14/18
11/14
08:45
11/14/18
08:45
Hot Stocks
Progressive reports October EPS (6c) vs. 27c last year »

Reports October net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$6.35

0.15 (2.42%)

, APRN

Blue Apron

$1.22

-0.03 (-2.40%)

08:45
11/14/18
11/14
08:45
11/14/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HCLP

Hi-Crush Partners

$6.35

0.15 (2.42%)

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

BPL

Buckeye Partners

$31.66

-0.535 (-1.66%)

ECYT

Endocyte

$23.59

0.03 (0.13%)

AAXJ

iShares MSCI All Country Asia Ex Japan

$64.36

1.13 (1.79%)

EWZ

MSCI Brazil Index

$38.32

-0.6 (-1.54%)

NEPT

Neptune Wellness

$3.20

-0.14 (-4.19%)

CRON

Cronos Group

$8.29

-0.15 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

08:45
11/14/18
11/14
08:45
11/14/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar was…

08:45
11/14/18
11/14
08:45
11/14/18
08:45
General news
Breaking General news story  »

Federal Reserve Vice…

UEIC

Universal Electronics

$33.29

-1.99 (-5.64%)

08:44
11/14/18
11/14
08:44
11/14/18
08:44
Upgrade
Universal Electronics rating change  »

Universal Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.33

-0.47 (-1.53%)

, VZ

Verizon

$58.67

-0.05 (-0.09%)

08:43
11/14/18
11/14
08:43
11/14/18
08:43
Conference/Events
Morgan Stanley to hold a conference »

European Tech, Media…

T

AT&T

$30.33

-0.47 (-1.53%)

VZ

Verizon

$58.67

-0.05 (-0.09%)

LBTYA

Liberty Global

$23.67

-0.3 (-1.25%)

DISCA

Discovery

$32.11

-0.26 (-0.80%)

CCI

Crown Castle

$110.70

0.92 (0.84%)

TMUS

T-Mobile

$68.45

0.61 (0.90%)

ZAYO

Zayo Group

$24.05

1.54 (6.84%)

ERIC

Ericsson

$8.92

0.17 (1.94%)

SCMN

Swisscom

$0.00

(0.00%)

ASML

ASML

$171.00

2 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 26

    Nov

TDOC

Teladoc

$58.56

-2.01 (-3.32%)

08:43
11/14/18
11/14
08:43
11/14/18
08:43
Hot Stocks
Teladoc announces collaborative antibiotics study with USC, Northwestern »

Teladoc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

PGR

Progressive

$71.63

-0.28 (-0.39%)

08:40
11/14/18
11/14
08:40
11/14/18
08:40
Earnings
Progressive reports October EPS (6c) vs. 27c last year »

Reports October net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:40
11/14/18
11/14
08:40
11/14/18
08:40
General news
U.S. CPI rose 0.3% in October »

U.S. CPI rose 0.3% in…

MDRX

Allscripts

$9.89

-0.26 (-2.56%)

08:40
11/14/18
11/14
08:40
11/14/18
08:40
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$158.15

0.65 (0.41%)

08:40
11/14/18
11/14
08:40
11/14/18
08:40
Conference/Events
Air Products management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.